 | • レポートコード：D005-00589 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：化学・材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、限局性自己免疫疾患診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。限局性自己免疫疾患診断の種類別市場規模（多発性硬化症、1型糖尿病、橋本甲状腺炎、特発性血小板減少性紫斑病、その他）、用途別市場規模（病院、クリニック、研究所、試験室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Hoffmann-La Roche Ltd、AESKU.Diagnostics GmbH & Co. KG、Beckman Coulter, Inc.、Siemens Healthineers、EUROIMMUN AG、Abbott Laboratories、Crescendo Bioscience, Inc.、Quest Diagnostics、SQI Diagnostics、INOVA Diagnostics, Inc.、bioMerieux SA、Bio-Rad Laboratories, Inc.、Hemagen Diagnostics, Inc. ・地域別グローバル市場分析 2015年-2020年 ・限局性自己免疫疾患診断の北米市場（アメリカ、カナダ、メキシコ） ・限局性自己免疫疾患診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・限局性自己免疫疾患診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・限局性自己免疫疾患診断の南米市場（ブラジル、アルゼンチン） ・限局性自己免疫疾患診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：多発性硬化症、1型糖尿病、橋本甲状腺炎、特発性血小板減少性紫斑病、その他 ・用途別分析：病院、クリニック、研究所、試験室 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Localized Autoimmune Disease Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Localized Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Localized Autoimmune Disease Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Localized Autoimmune Disease Diagnostics market has been segmented into:
Multiple Sclerosis
Type 1 Diabetes
Hashimoto’s Thyroiditis
Idiopathic Thrombocytopenic Purpura
Others
By Application, Localized Autoimmune Disease Diagnostics has been segmented into:
Hospital
Clinic
Research Institute
Laboratories
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Localized Autoimmune Disease Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Localized Autoimmune Disease Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Localized Autoimmune Disease Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Localized Autoimmune Disease Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Localized Autoimmune Disease Diagnostics Market Share Analysis
Localized Autoimmune Disease Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Localized Autoimmune Disease Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Localized Autoimmune Disease Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Localized Autoimmune Disease Diagnostics are:
Hoffmann-La Roche Ltd
AESKU.Diagnostics GmbH & Co. KG
Beckman Coulter, Inc.
Siemens Healthineers
EUROIMMUN AG
Abbott Laboratories
Crescendo Bioscience, Inc.
Quest Diagnostics
SQI Diagnostics
INOVA Diagnostics, Inc.
bioMerieux SA
Bio-Rad Laboratories, Inc.
Hemagen Diagnostics, Inc.
Table of Contents
1 Localized Autoimmune Disease Diagnostics Market Overview
1.1 Product Overview and Scope of Localized Autoimmune Disease Diagnostics
1.2 Classification of Localized Autoimmune Disease Diagnostics by Type
1.2.1 Global Localized Autoimmune Disease Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Type in 2019
1.2.3 Multiple Sclerosis
1.2.4 Type 1 Diabetes
1.2.5 Hashimoto’s Thyroiditis
1.2.6 Idiopathic Thrombocytopenic Purpura
1.2.7 Others
1.3 Global Localized Autoimmune Disease Diagnostics Market by Application
1.3.1 Overview: Global Localized Autoimmune Disease Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.4 Global Localized Autoimmune Disease Diagnostics Market by Regions
1.4.1 Global Localized Autoimmune Disease Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Localized Autoimmune Disease Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Localized Autoimmune Disease Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Localized Autoimmune Disease Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Localized Autoimmune Disease Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Localized Autoimmune Disease Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Localized Autoimmune Disease Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Hoffmann-La Roche Ltd
2.1.1 Hoffmann-La Roche Ltd Details
2.1.2 Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Hoffmann-La Roche Ltd SWOT Analysis
2.1.4 Hoffmann-La Roche Ltd Product and Services
2.1.5 Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 AESKU.Diagnostics GmbH & Co. KG
2.2.1 AESKU.Diagnostics GmbH & Co. KG Details
2.2.2 AESKU.Diagnostics GmbH & Co. KG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AESKU.Diagnostics GmbH & Co. KG SWOT Analysis
2.2.4 AESKU.Diagnostics GmbH & Co. KG Product and Services
2.2.5 AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beckman Coulter, Inc.
2.3.1 Beckman Coulter, Inc. Details
2.3.2 Beckman Coulter, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Beckman Coulter, Inc. SWOT Analysis
2.3.4 Beckman Coulter, Inc. Product and Services
2.3.5 Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Siemens Healthineers SWOT Analysis
2.4.4 Siemens Healthineers Product and Services
2.4.5 Siemens Healthineers Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 EUROIMMUN AG
2.5.1 EUROIMMUN AG Details
2.5.2 EUROIMMUN AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 EUROIMMUN AG SWOT Analysis
2.5.4 EUROIMMUN AG Product and Services
2.5.5 EUROIMMUN AG Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott Laboratories
2.6.1 Abbott Laboratories Details
2.6.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott Laboratories SWOT Analysis
2.6.4 Abbott Laboratories Product and Services
2.6.5 Abbott Laboratories Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Crescendo Bioscience, Inc.
2.7.1 Crescendo Bioscience, Inc. Details
2.7.2 Crescendo Bioscience, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Crescendo Bioscience, Inc. SWOT Analysis
2.7.4 Crescendo Bioscience, Inc. Product and Services
2.7.5 Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Quest Diagnostics
2.8.1 Quest Diagnostics Details
2.8.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Quest Diagnostics SWOT Analysis
2.8.4 Quest Diagnostics Product and Services
2.8.5 Quest Diagnostics Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 SQI Diagnostics
2.9.1 SQI Diagnostics Details
2.9.2 SQI Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 SQI Diagnostics SWOT Analysis
2.9.4 SQI Diagnostics Product and Services
2.9.5 SQI Diagnostics Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 INOVA Diagnostics, Inc.
2.10.1 INOVA Diagnostics, Inc. Details
2.10.2 INOVA Diagnostics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 INOVA Diagnostics, Inc. SWOT Analysis
2.10.4 INOVA Diagnostics, Inc. Product and Services
2.10.5 INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 bioMerieux SA
2.11.1 bioMerieux SA Details
2.11.2 bioMerieux SA Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 bioMerieux SA SWOT Analysis
2.11.4 bioMerieux SA Product and Services
2.11.5 bioMerieux SA Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Bio-Rad Laboratories, Inc.
2.12.1 Bio-Rad Laboratories, Inc. Details
2.12.2 Bio-Rad Laboratories, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Bio-Rad Laboratories, Inc. SWOT Analysis
2.12.4 Bio-Rad Laboratories, Inc. Product and Services
2.12.5 Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Hemagen Diagnostics, Inc.
2.13.1 Hemagen Diagnostics, Inc. Details
2.13.2 Hemagen Diagnostics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Hemagen Diagnostics, Inc. SWOT Analysis
2.13.4 Hemagen Diagnostics, Inc. Product and Services
2.13.5 Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Localized Autoimmune Disease Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Localized Autoimmune Disease Diagnostics Players Market Share
3.2.2 Top 10 Localized Autoimmune Disease Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Localized Autoimmune Disease Diagnostics Revenue and Market Share by Regions
4.2 North America Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Localized Autoimmune Disease Diagnostics Revenue by Countries
5.1 North America Localized Autoimmune Disease Diagnostics Revenue by Countries (2015-2020)
5.2 USA Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Localized Autoimmune Disease Diagnostics Revenue by Countries
6.1 Europe Localized Autoimmune Disease Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Countries
7.1 Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue by Countries (2015-2020)
7.2 China Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Localized Autoimmune Disease Diagnostics Revenue by Countries
8.1 South America Localized Autoimmune Disease Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Localized Autoimmune Disease Diagnostics by Countries
9.1 Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Localized Autoimmune Disease Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Localized Autoimmune Disease Diagnostics Market Forecast by Type (2019-2024)
10.3 Multiple Sclerosis Revenue Growth Rate (2015-2025)
10.4 Type 1 Diabetes Revenue Growth Rate (2015-2025)
10.5 Hashimoto’s Thyroiditis Revenue Growth Rate (2015-2025)
10.6 Idiopathic Thrombocytopenic Purpura Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Localized Autoimmune Disease Diagnostics Market Segment by Application
11.1 Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Localized Autoimmune Disease Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Research Institute Revenue Growth (2015-2020)
11.6 Laboratories Revenue Growth (2015-2020)
12 Global Localized Autoimmune Disease Diagnostics Market Size Forecast (2021-2025)
12.1 Global Localized Autoimmune Disease Diagnostics Market Size Forecast (2021-2025)
12.2 Global Localized Autoimmune Disease Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Localized Autoimmune Disease Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Localized Autoimmune Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Localized Autoimmune Disease Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Localized Autoimmune Disease Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Hoffmann-La Roche Ltd Corporate Information, Location and Competitors
Table 6. Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Major Business
Table 7. Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Hoffmann-La Roche Ltd SWOT Analysis
Table 9. Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Product and Solutions
Table 10. Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AESKU.Diagnostics GmbH & Co. KG Corporate Information, Location and Competitors
Table 12. AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Major Business
Table 13. AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. AESKU.Diagnostics GmbH & Co. KG SWOT Analysis
Table 15. AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Product and Solutions
Table 16. AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Beckman Coulter, Inc. Corporate Information, Location and Competitors
Table 18. Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Major Business
Table 19. Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Beckman Coulter, Inc. SWOT Analysis
Table 21. Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 22. Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Siemens Healthineers Corporate Information, Location and Competitors
Table 24. Siemens Healthineers Localized Autoimmune Disease Diagnostics Major Business
Table 25. Siemens Healthineers Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Siemens Healthineers SWOT Analysis
Table 27. Siemens Healthineers Localized Autoimmune Disease Diagnostics Product and Solutions
Table 28. Siemens Healthineers Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. EUROIMMUN AG Corporate Information, Location and Competitors
Table 30. EUROIMMUN AG Localized Autoimmune Disease Diagnostics Major Business
Table 31. EUROIMMUN AG Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. EUROIMMUN AG SWOT Analysis
Table 33. EUROIMMUN AG Localized Autoimmune Disease Diagnostics Product and Solutions
Table 34. EUROIMMUN AG Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Laboratories Corporate Information, Location and Competitors
Table 36. Abbott Laboratories Localized Autoimmune Disease Diagnostics Major Business
Table 37. Abbott Laboratories Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Abbott Laboratories SWOT Analysis
Table 39. Abbott Laboratories Localized Autoimmune Disease Diagnostics Product and Solutions
Table 40. Abbott Laboratories Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Crescendo Bioscience, Inc. Corporate Information, Location and Competitors
Table 42. Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Major Business
Table 43. Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Crescendo Bioscience, Inc. SWOT Analysis
Table 45. Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 46. Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Quest Diagnostics Corporate Information, Location and Competitors
Table 48. Quest Diagnostics Localized Autoimmune Disease Diagnostics Major Business
Table 49. Quest Diagnostics Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Quest Diagnostics SWOT Analysis
Table 51. Quest Diagnostics Localized Autoimmune Disease Diagnostics Product and Solutions
Table 52. Quest Diagnostics Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. SQI Diagnostics Corporate Information, Location and Competitors
Table 54. SQI Diagnostics Localized Autoimmune Disease Diagnostics Major Business
Table 55. SQI Diagnostics Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. SQI Diagnostics SWOT Analysis
Table 57. SQI Diagnostics Localized Autoimmune Disease Diagnostics Product and Solutions
Table 58. SQI Diagnostics Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. INOVA Diagnostics, Inc. Corporate Information, Location and Competitors
Table 60. INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Major Business
Table 61. INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. INOVA Diagnostics, Inc. SWOT Analysis
Table 63. INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 64. INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. bioMerieux SA Corporate Information, Location and Competitors
Table 66. bioMerieux SA Localized Autoimmune Disease Diagnostics Major Business
Table 67. bioMerieux SA Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. bioMerieux SA SWOT Analysis
Table 69. bioMerieux SA Localized Autoimmune Disease Diagnostics Product and Solutions
Table 70. bioMerieux SA Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Bio-Rad Laboratories, Inc. Corporate Information, Location and Competitors
Table 72. Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Major Business
Table 73. Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 74. Bio-Rad Laboratories, Inc. SWOT Analysis
Table 75. Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 76. Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Hemagen Diagnostics, Inc. Corporate Information, Location and Competitors
Table 78. Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Major Business
Table 79. Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 80. Hemagen Diagnostics, Inc. SWOT Analysis
Table 81. Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Product and Solutions
Table 82. Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Localized Autoimmune Disease Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 84. Global Localized Autoimmune Disease Diagnostics Revenue Share by Players (2015-2020)
Table 85. Global Localized Autoimmune Disease Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Regions (2015-2020)
Table 87. North America Localized Autoimmune Disease Diagnostics Revenue by Countries (2015-2020)
Table 88. North America Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 89. Europe Localized Autoimmune Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Localized Autoimmune Disease Diagnostics Revenue by Countries (2015-2020)
Table 92. South America Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Localized Autoimmune Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 95. Global Localized Autoimmune Disease Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 96. Global Localized Autoimmune Disease Diagnostics Revenue Share by Type (2015-2020)
Table 97. Global Localized Autoimmune Disease Diagnostics Revenue Forecast by Type (2021-2025)
Table 98. Global Localized Autoimmune Disease Diagnostics Revenue by Application (2015-2020)
Table 99. Global Localized Autoimmune Disease Diagnostics Revenue Share by Application (2015-2020)
Table 100. Global Localized Autoimmune Disease Diagnostics Revenue Forecast by Application (2021-2025)
Table 101. Global Localized Autoimmune Disease Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Localized Autoimmune Disease Diagnostics Picture
Figure 2. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Type in 2019
Figure 3. Multiple Sclerosis Picture
Figure 4. Type 1 Diabetes Picture
Figure 5. Hashimoto's Thyroiditis Picture
Figure 6. Idiopathic Thrombocytopenic Purpura Picture
Figure 7. Others Picture
Figure 8. Localized Autoimmune Disease Diagnostics Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Research Institute Picture
Figure 12. Laboratories Picture
Figure 13. Global Localized Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Localized Autoimmune Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Localized Autoimmune Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Localized Autoimmune Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Localized Autoimmune Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Localized Autoimmune Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Localized Autoimmune Disease Diagnostics Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Localized Autoimmune Disease Diagnostics Revenue Market Share in 2019
Figure 22. Global Top 10 Players Localized Autoimmune Disease Diagnostics Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Localized Autoimmune Disease Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 26. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Regions in 2018
Figure 27. North America Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Europe Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. South America Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. North America Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 33. North America Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 34. USA Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Canada Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. Europe Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 39. Germany Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. UK Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. France Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Russia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Italy Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 46. China Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Japan Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Korea Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. India Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. South America Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 52. South America Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 53. Brazil Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Localized Autoimmune Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. UAE Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Localized Autoimmune Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 61. Global Localized Autoimmune Disease Diagnostics Revenue Share by Type (2015-2020)
Figure 62. Global Localized Autoimmune Disease Diagnostics Revenue Share by Type in 2019
Figure 63. Global Localized Autoimmune Disease Diagnostics Market Share Forecast by Type (2021-2025)
Figure 64. Global Multiple Sclerosis Revenue Growth Rate (2015-2020)
Figure 65. Global Type 1 Diabetes Revenue Growth Rate (2015-2020)
Figure 66. Global Hashimoto's Thyroiditis Revenue Growth Rate (2015-2020)
Figure 67. Global Idiopathic Thrombocytopenic Purpura Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Localized Autoimmune Disease Diagnostics Revenue Share by Application (2015-2020)
Figure 70. Global Localized Autoimmune Disease Diagnostics Revenue Share by Application in 2019
Figure 71. Global Localized Autoimmune Disease Diagnostics Market Share Forecast by Application (2021-2025)
Figure 72. Global Hospital Revenue Growth Rate (2015-2020)
Figure 73. Global Clinic Revenue Growth Rate (2015-2020)
Figure 74. Global Research Institute Revenue Growth Rate (2015-2020)
Figure 75. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 76. Global Localized Autoimmune Disease Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Localized Autoimmune Disease Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Localized Autoimmune Disease Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Europe Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 82. South America Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Localized Autoimmune Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
全身性自己免疫疾患診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Systemic Autoimmune Disease Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Syste…- 感染症検査における分子診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- ポイントオブケア感染症診断/検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point-of-Care Infectious Disease Diagnostics/Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1257.8 million by 2025, from USD 1026.6 mill…
- 遺伝病診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genetic Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genetic Disease Di…
- 感染症用POC検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point of Care Testing for Infectious Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …